Efficacy and safety of different doses and retreatment of rituximab: a randomised, placebo-controlled trial in patients who are biological naive with active rheumatoid arthritis and an inadequate response to methotrexate (Study Evaluating Rituximab's Efficacy in MTX iNadequate rEsponders (SERENE))
利妥昔单抗不同剂量和再治疗的疗效和安全性：一项针对生物学初治、活动性类风湿关节炎且对甲氨蝶呤反应不足患者的随机、安慰剂对照试验（评估利妥昔单抗对甲氨蝶呤反应不足患者的疗效研究 (SERENE)）
期刊:Annals of the Rheumatic Diseases
影响因子:20.6
doi:10.1136/ard.2009.119933
Emery, P; Deodhar, A; Rigby, W F; Isaacs, J D; Combe, B; Racewicz, A J; Latinis, K; Abud-Mendoza, C; Szczepanski, L J; Roschmann, R A; Chen, A; Armstrong, G K; Douglass, W; Tyrrell, H
